Neurocrine Biosciences shares owned by Lazard Asset Management
Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Lazard Asset Management
from 13F filings
Historical chart of Lazard Asset Management investment in Neurocrine Biosciences
Tip: Access up to 7 years of quarterly data
All positions including Neurocrine Biosciences held by Lazard Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Neurocrine Biosciences by Lazard Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $5.7M | 41k | 140.38 |
| 2025-06-30 | $4.6M | 36k | 125.68 |
| 2025-03-31 | $6.3M | 57k | 110.59 |
| 2024-12-31 | $8.1M | 59k | 136.48 |
| 2024-09-30 | $8.6M | 75k | 115.21 |
| 2024-06-30 | $8.5M | 61k | 137.66 |
| 2024-03-31 | $7.6M | 55k | 137.90 |
| 2023-12-31 | $6.1M | 46k | 131.75 |
| 2023-09-30 | $3.1M | 27k | 112.48 |
| 2023-06-30 | $175k | 1.9k | 94.09 |
| 2023-03-31 | $4.6M | 45k | 101.20 |
| 2022-12-31 | $505k | 4.2k | 119.24 |
| 2022-09-30 | $127k | 1.2k | 105.57 |
| 2022-06-30 | $74k | 765 | 96.73 |
| 2022-03-31 | $74k | 791 | 93.55 |
| 2021-12-31 | $4.1M | 49k | 85.16 |
| 2021-09-30 | $3.3M | 34k | 95.90 |
| 2021-03-31 | $88k | 915 | 96.17 |
| 2020-12-31 | $94k | 988 | 95.14 |
| 2020-09-30 | $92k | 960 | 95.83 |
| 2020-06-30 | $142k | 1.2k | 121.16 |
| 2020-03-31 | $156k | 1.8k | 86.05 |
| 2019-12-31 | $59k | 554 | 106.50 |
| 2019-09-30 | $129k | 1.4k | 89.58 |
| 2019-06-30 | $92k | 1.1k | 83.64 |
| 2019-03-31 | $96k | 1.1k | 87.27 |
| 2018-12-31 | $78k | 1.1k | 70.91 |
| 2018-06-30 | $1.0M | 11k | 98.16 |
| 2017-03-31 | $549k | 13k | 43.23 |
| 2016-12-31 | $178k | 4.6k | 38.70 |
| 2016-09-30 | $2.5M | 49k | 50.63 |
| 2016-06-30 | $3.1M | 68k | 45.44 |
| 2015-12-31 | $189k | 3.4k | 56.33 |
| 2015-09-30 | $233k | 5.9k | 39.63 |
| 2015-06-30 | $209k | 4.4k | 47.61 |
| 2015-03-31 | $157k | 4.0k | 39.60 |